Trial Profile
A Phase 2, Multi-center, Randomized, Double-masked, Placebo (Vehicle)-Controlled Clinical Study With an Open Label Comparator Arm to Assess the Efficacy, Safety and Tolerability of Topical CyclASol for Treatment of Dry Eye Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2020
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Ciclosporin
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Novaliq
- 17 Oct 2018 According to a Novaliq media release, data will be presented during the Ophthalmology Innovation Summit (OIS@AAO) in 2018
- 09 Nov 2017 According to a Novaliq media release, data will be presented at AAO 2017, the American Academy of Ophthalmologys 121st annual meeting.
- 28 Mar 2017 Status changed from active, no longer recruiting to completed.